Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

537
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
537

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unbiased avidity-based isolation of antigen-specific T cells.

Journal for immunotherapy of cancer·2026
Same author

Agent-based modeling of cellular dynamics in adoptive cell therapy.

Communications biology·2026
Same author

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Research square·2025
Same author

Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues.

Nature communications·2025
Same author

Dissecting the effects of <sup>223</sup>Radium on the bone microenvironment.

Acta pharmaceutica Sinica. B·2025
Same author

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity.

Journal of immunology (Baltimore, Md. : 1950)·2025

Related Experiment Video

Updated: Oct 3, 2025

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.5K

223Ra Induces Transient Functional Bone Marrow Toxicity.

Maria Parlani1, Francesco Boccalatte2, Anna Yeaton3

  • 1Genitourinary Medical Oncology Department and David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas M.D. Anderson Cancer Center, Houston, Texas.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|February 18, 2022
PubMed
Summary
This summary is machine-generated.

Radium-223 (223Ra) causes temporary bone marrow damage, affecting blood cell counts. However, bone marrow function fully recovers within 40 days, indicating no long-term myelotoxicity for cancer patients.

Keywords:
223Rabone marrowmyelotoxicity

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

13.0K
Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
14:43

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation

Published on: October 1, 2012

18.5K

Related Experiment Videos

Last Updated: Oct 3, 2025

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.5K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

13.0K
Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
14:43

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation

Published on: October 1, 2012

18.5K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Hematology

Background:

  • Radium-223 (223Ra) is an alpha-particle-emitting radionuclide used for metastatic prostate cancer.
  • Clinical use of 223Ra has shown increased rates of neutropenia and thrombocytopenia, suggesting potential myelosuppression.

Purpose of the Study:

  • To investigate the effects of 223Ra on bone marrow biology.
  • To determine if 223Ra causes long-term bone marrow damage.

Main Methods:

  • Flow cytometry
  • Single-cell RNA sequencing
  • 3D multiphoton microscopy
  • Bone marrow transplantation analyses

Main Results:

  • 223Ra accumulated in bone, causing localized radiation damage and adipocyte infiltration.
  • Transient, non-specific cytotoxicity was observed in hematopoietic stem and progenitor cells.
  • Peripheral blood cell counts decreased but recovered within 40 days.
  • Full hematopoietic reconstitution occurred, indicating no permanent impairment.

Conclusions:

  • 223Ra causes reversible effects on bone marrow cells.
  • Long-term myelotoxicity is excluded, supporting the safety of 223Ra therapy.